Related Experiment Video
Updated: Jul 30, 2026

12:31
In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Generalizable Prediction of Alzheimer Disease Pathologies with a Scalable Annotation Tool and an High-Accuracy Model
Medrxiv : the Preprint Server for Health Sciences
|February 20, 2025
Summary
This study introduces an automated computational pipeline for Alzheimer disease (AD) neuropathology analysis. The tool rapidly and accurately quantifies amyloid pathology in brain tissue, aiding AD research.
Area of Science:
- Neuropathology
- Computational Biology
- Artificial Intelligence
Background:
- Characterizing Alzheimer disease (AD) neuropathology is labor-intensive and prone to variability.
- Current methods hinder the analysis of large datasets linking AD clinical features to molecular pathogenesis.
Purpose of the Study:
- To develop a high-throughput, unbiased computational pipeline for automated neuropathological analysis of AD.
- To overcome limitations of traditional methods in assessing AD brain tissue pathology.
Main Methods:
- Designed an annotation tool and computational pipeline using Mask Regional-Convolutional Neural Network (Mask R-CNN) for image analysis.
- Trained Mask R-CNN on expert-annotated digital microscopic images of postmortem AD brain tissue.
- Utilized QuPath platform for ground truth annotation and consensus building among experts.
Main Results:
- The automated pipeline achieved high accuracy (94.6%) in identifying amyloid pathology in independent samples.
- Quantitative measurements of amyloid pathology correlated significantly with expert neuropathological assessments (CERAD) and cognitive decline (CDR).
- The system demonstrated generalizable pathology feature detection.
Conclusions:
- The developed computational pipeline enables rapid, unbiased, and quantitative neuropathological analysis of large AD tissue collections.
- This approach facilitates integration with clinical and multi-omic data for a comprehensive understanding of AD.
- The tool significantly reduces time and cost associated with traditional neuropathology assessments.

